Get the Stockscreener App
0.00
100.00%
-0.1815
Affimed N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
See More
Previous Close:
$0.1815
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$2.13M
Revenue:
$19.91M
Net Income/Loss:
$-127.11M
P/E Ratio:
0.00
EPS:
-8.428
Net Cash Flow:
$-132.44M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$8.95
Affimed N V Stock (AFMD) Company Profile
Compare AFMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AFMD
Affimed N V
|
0.00 | 2.13M | 19.91M | -127.11M | -132.44M | -8.428 |
|
ONC
Beone Medicines Ltd Adr
|
258.70 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.40 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.59 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
489.49 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Affimed N V Stock (AFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-12-22 | Initiated | H.C. Wainwright | Buy |
| Oct-10-22 | Downgrade | Stifel | Buy → Hold |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Mar-31-22 | Initiated | Piper Sandler | Overweight |
| Feb-23-22 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-21-21 | Initiated | Truist | Buy |
| Sep-30-21 | Initiated | Stifel | Buy |
| Mar-31-21 | Initiated | Credit Suisse | Outperform |
| Mar-28-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-14-17 | Initiated | SunTrust | Buy |
| Aug-12-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| May-19-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Dec-10-15 | Initiated | Laidlaw | Buy |
| Dec-04-15 | Initiated | Wells Fargo | Outperform |
| Sep-09-15 | Initiated | Jefferies | Hold |
| Aug-06-15 | Reiterated | Oppenheimer | Outperform |
| Jun-22-15 | Reiterated | Jefferies | Buy |
View All
Affimed N V Stock (AFMD) Latest News
Affimed (AFMD) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Northern Trust Corp Takes $218,000 Position in Affimed (NASDAQ:AFMD) - Defense World
Top Penny Stocks To ResearchMay 18th - MarketBeat
3 Penny Stocks to Watch Now, 5/20/25 - The Globe and Mail
Affimed (NASDAQ:AFMD) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Affimed’s ASCO ‘Hail Mary’ As Survival Chances Slim - insights.citeline.com
New Development for AFMD Options as May 20th Approaches | AFMD S - GuruFocus
Three new option listings and fifteen option delistings on May 20th - TipRanks
New Development for AFMD Options as May 20th Approaches | AFMD Stock News - GuruFocus
Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings - Benzinga
Affimed (NASDAQ:AFMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Affimed FY2025 EPS Estimate Boosted by Cantor Fitzgerald - Defense World
Affimed (NASDAQ:AFMD) Cut to Hold at Cantor Fitzgerald - Defense World
US Stocks Edge Higher; Consumer Sentiment Falls In May - Benzinga
Affimed (NASDAQ:AFMD) Cut to “Hold” at Leerink Partnrs - Defense World
HC Wainwright Downgrades Affimed (NASDAQ:AFMD) to Neutral - Defense World
Q1 Earnings Estimate for Affimed Issued By Leerink Partnrs - Defense World
HC Wainwright & Co. Downgrades Affimed N.V. (LSE:0HL9) - Nasdaq
Wells Fargo & Company Reiterates Equal Weight Rating for Affimed (NASDAQ:AFMD) - Defense World
Affimed shares crash after filing for the opening of insolvency proceedings - MSN
Cantor Fitzgerald cuts Affimed stock rating on insolvency news - Investing.com Australia
Cantor Fitzgerald cuts Affimed stock rating on insolvency news By Investing.com - Investing.com Nigeria
Affimed shares to be delisted from Nasdaq after insolvency filing By Investing.com - Investing.com South Africa
Affimed (AFMD) Downgraded to Neutral by HC Wainwright & Co. | AF - GuruFocus
Affimed downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Affimed receives Nasdaq delisting notice - TipRanks
Affimed (AFMD) Faces Delisting from Nasdaq | AFMD Stock News - GuruFocus
Cantor Fitzgerald Downgrades Affimed to Neutral From Overweight - marketscreener.com
Affimed Announces Receipt of Nasdaq Delisting Notice | AFMD Stoc - GuruFocus
Affimed Faces Nasdaq Delisting Following Insolvency Filing - TipRanks
Affimed shares to be delisted from Nasdaq after insolvency filing - Investing.com
HC Wainwright Downgrades Affimed N.V to Neutral From Buy - marketscreener.com
Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) - Seeking Alpha
Affimed (AFMD) Faces Downgrade Amid Insolvency Proceedings | AFM - GuruFocus
Affimed Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Affimed Stock to Be Delisted from Nasdaq, Trading Suspended May 20 Following Insolvency - Stock Titan
Wells Fargo Downgrades Affimed (AFMD) with New Price Target | AF - GuruFocus
Leerink Partners Downgrades Affimed N.V. (LSE:0HL9) - Nasdaq
Affimed (AFMD) Seeks Insolvency Proceedings Amid Financial Strug - GuruFocus
Leerink cuts Affimed stock target to $0.39, downgrades rating By Investing.com - Investing.com Canada
Health Care Stocks Face Broad Downturn As Sector Challenges Mount - Finimize
AFMD Stock Downgraded as Wells Fargo Slashes Price Target | AFMD - GuruFocus
Affimed (AFMD) Faces Downgrade Amid Insolvency Proceedings | AFMD Stock News - GuruFocus
Affimed downgraded to Equal Weight at Wells after insolvency filing - TipRanks
Wells Fargo Downgrades Affimed to Equalweight From Overweight; Shares Plunge - marketscreener.com
Crude Oil Gains 3%; US Inflation Eases In April - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
AFMD: Leerink Partners Downgrades Affimed with New Price Target - GuruFocus
Affimed (AFMD) Downgraded as Funding Prospects Dim | AFMD Stock News - GuruFocus
Affimed (AFMD) Files for Insolvency Amid Financial Challenges - GuruFocus
Affimed N V Stock (AFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):